Incidence, Predictors at Admission, and Impact of Worsening Renal Function among Patients Hospitalized with Heart Failure

Journal of the American College of Cardiology

Volumn 43, Issue 1, 2004, Pages 61-67

  Forman, Daniel E ^a   Butler, Javed ^b   Wang, Yongfei ^c   Abraham, William T ^d   O'Connor, Christopher M ^e   Gottlieb, Stephen S ^f   Loh, Evan ^g,o   Massie, Barry M ^h,i   Rich, Michael W ^j   Stevenson, Lynne Warner ^k   Young, James B ^l   Krumholz, Harlan M ^c,m,n  

^a BOSTON MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m QUALIDIGM   (United States)

ⁿ YALE NEW HAVEN HOSPITAL   (United States)

^o WYETH AYERST RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GEOGRAPHY; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 9144262490     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.031     Document Type: Article

References (19)

1. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-9.
2. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10.
3. Hall WD. Abnormalities of kidney function as a cause and a consequence of cardiovascular disease. Am J Med Sci 1999;317:176-82.
4. Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000;36 Suppl 3:S24-30.
5. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998;352:13-6.
6. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000;36:679-84.
7. Miller KH. Factors influencing selected lengths of ICU stay for coronary artery bypass patients. J Cardiovasc Nurs 1998;12:52-61.
8. Zanchetti A, Stella A. Cardiovascular disease and the kidney: an epidemiologic overview. J Cardiovasc Pharmacol 1999;33 Suppl 1:S1-6.
9. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure. Am J Cardiol 2000;85:1110-3.
10. Pitt B, Segal R, Martinez FA, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-52.
11. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003;9:13-25.
12. Walsh JF, Reznikoff M. Bootstrapping: a tool for clinical research. J Clin Psychol 1990;46:928-30.
13. Corcoran C, Mehta C, Senchaudhuri P. Power comparisons for tests of trend in dose-response studies. Stat Med 2000;19:3037-50.
14. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
15. Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 1984;69:57-64.
16. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999;138:285-90.
17. Friedrich EB, Muders F, Luchner A, Dietl O, Riegger GA, Elsner D. Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure. J Cardiovasc Pharmacol 1999;34:612-7.
18. Abassi Z, Gurbanov K, Rubinstein I, Better OS, Hoffman A, Winaver J. Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am J Physiol 1998;274:F766-74.
19. Gottlieb SS, Abraham WT, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002;8:136-41.